Evidence map›Paper›PMID 34377054›Full record

ArticleTurkish journal of biology = Turk biyoloji dergisi2021

The promising effects of BMP2 transfected mesenchymal stem cells on human osteosarcoma.

Ahmet Sinan Sari, Emre Demirçay, Ahmet Öztürk, Ayşen Terzi, Erdal Karaöz

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Turkish journal of biology = Turk biyoloji dergisi, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Ahmet Sinan SariDepartment of Orthopedics and Traumatology, Faculty of Medicine, Başkent University, Ankara Training and Research Hospital, Ankara Turkey.ORCID https://orcid.org/0000-0002-5429-1929
Emre DemirçayDepartment of Orthopedics and Traumatology, Faculty of Medicine, Başkent University, Istanbul Training and Research Hospital, İstanbul Turkey.ORCID https://orcid.org/0000-0003-1274-4288
Ahmet ÖztürkStem Cell and Gene Therapy Research and Application Center, Kocaeli Turkey.ORCID https://orcid.org/0000-0001-8723-9417
Ayşen TerziDepartment of Pathology, Faculty of Medicine, Başkent University, Ankara Training and Research Hospital, Ankara Turkey.ORCID https://orcid.org/0000-0002-1225-1320
Erdal KaraözStem Cell and Gene Therapy Research and Application Center, Kocaeli Turkey.ORCID https://orcid.org/0000-0002-9992-833X
Başkent University · TRBaşkent University Hospital · TRIstinye University · TRKocaeli Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selective targeting of transfected mesenchymal stem cells (MSCs) carrying specific antioncogenes to the tumor was suggested as a treatment option. Bone morphogenetic protein-2 (BMP2) was shown to inhibit the proliferation and aggressiveness of osteosarcoma (OS) cells. Here, we aimed to assess the homing efficiency of intraperitoneally administered hMSCs transfected with

Indexed as

BMP2Intraperitoneallung metastasisosteogenic differentiationtargetingtumor

Identifiers

PMID34377054
PMCPMC8313938
OpenAlexW3173984402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.